Figures & data
Figure 1. Consort diagram of the cohort of 2893 consecutive men treated with combined radiotherapy in Stockholm 1998–2010 and reasons for exclusion from the study cohort.
Table 1. Patient characteristics by Cambridge prognostic group risk classification.
Table 2. Survival and failure status by CPG risk classification.
Figure 2. Cumulative incidence estimates of death and failure by risk group. (a) Cause of death, total cohort; (b) prostate cancer-specific death by risk group (PCSD); (c) any death by risk group (AD), (d) cause of first failure, total cohort; (e) prostate cancer-specific failure (PCSF) as first failure by risk group (PCSF); (f) any failure by risk group (AF). Death of other cause (DOC), death of other cause as first failure (DOCF), risk group; L: low; IF: intermediate favourable; IU: intermediate unfavourable; HF: high risk favourable; HU: high risk unfavourable. Numbers at risk per risk-group regarding AD and AF are presented in Supplementary Table 1a and b, respectively.
Table 3. Competing risk multivariate regression analysis (sHR, CI 95%, p) for failure and death, by Cambridge prognostic group risk classification.